EMPL 1st Trilogue on the Protection of workers from the risks related to exposure to ASBESTOS at work

ENVI - Presentation of the Pharmaceutical Package

SANT Subcommittee

EP Plenary session - EU Global Health Strategy

COVI Special Committee - Exchange of views with Emer Cooke, Executive Director of the European Medicines Agency (EMA)

COVI Special Committee - Exchange of views with Valdis DOMBROVSKIS, Executive Vice President of the European Commission, Commissioner for Trade

COVI Special Committee - Exchange of views with Jutta  URPILAINEN, Commissioner for International Partnerships

COVI special Committee - Public hearing '  The impact of the pandemic on fundamental rights ' - Exchange of views with Michael O’Flaherty, Director, European Fundamental Rights Agency

COVI Special Committee - Public hearing ' Impact of the Pandemic on EU Democracies '

EP Plenary session - Surge of respiratory infections and the shortage of medication in Europe

EP Plenary session - O.Q.: - Revision of the Medical Devices Regulation – how to ensure the availability of medical devices

EP Plenary session - Prevention, management and better care of diabetes in the EU on the occasion of World Diabetes Day

ENVI Committee - Exchange of views with Emer Cooke, Executive Director of the European Medicines Agency (EMA)

EP Plenary session - Mental health

EP Plenary session - Oral question - COVID-19 – Sustaining EU preparedness and response: looking ahead

The Parliament discusses with the Commission on how to coordinate member states’ measures more effectively, in light of rising COVID-19 cases across the EU. Statements of Stella KYRIAKIDES, European Commissioner for Health and Food Safety, Esther de LANGE (EPP, NL), Véronique TRILLET-LENOIR (Renew, FR), Tilly METZ (Greens/EFA, LU), Robert ROOS (ECR, NL), KONEČNÁ Kateřina (The Left, CZ), Simona BONAFÈ (S&D, IT).

Coordination of Member States’ measures in light of increasing cases of COVID-19 in the EU: extracts from the debate

MEPs discuss the protection of workers from asbestos during a plenary session debate in Strasbourg. MEPs debate.

Protecting workers from asbestos: MEPs debate

During the plenary session of the European Parliament in Strasbourg (4-7 October 2021), MEPs debate on the EU Health Emergency Preparedness and Response Authority to ensure a coordinated EU approach for future health crisis and the role of the European Parliament.

EU Health Emergency Preparedness and Response Authority: MEPs debate (part 1/2)

During the plenary session of the European Parliament in Strasbourg (4-7 October 2021), MEPs debate the protection of persons with disabilities through petitions.

The protection of persons with disabilities through petitions - lessons learnt: MEPs debate

During the plenary session (13-16 September 2021) in the European Parliament in Strasbourg, MEPs debate on the fair working conditions, rights and social protection for platform workers - New forms of employment linked to digital development. (Second part of the debate)

Fair working conditions, rights and social protection for platform workers - New forms of employment linked to digital development: MEPs debate (Part 2/2)

During the plenary session (13-16 September 2021) in the European Parliament in Strasbourg, MEPs participate in the joint debate on the health and disease prevention and will debate and vote on two laws to strengthen the European Centre for Disease Prevention and Control and better tackle cross-border health threats. Opening statements by Margarita DE LA PISA CARRIÓN (ECR, ES) and Véronique TRILLET-LENOIR (Renew, FR), rapporteurs, and by Stella KYRIAKIDES, European Commissioner for Health and Food Safety.

Joint debate on the health and disease prevention: opening statements by Margarita DE LA PISA CARRIÓN (ECR, ES), Véronique TRILLET-LENOIR (Renew, FR), rapporteurs and by Stella KYRIAKIDES, European Commissioner for Health and Food Safety

Véronique TRILLET-LENOIR (Renew, FR), presents her draft report "Strengthening Europe in the fight against cancer – towards a comprehensive and coordinated strategy" to the Members of the Beating Cancer Committee, in the European Parliament in Brussels. The draft proposes concrete actions and tools in the fields of health and research, including ambitious legislative proposals to reduce tobacco and alcohol consumption, promote healthy eating and regular physical activity, and encourage vaccination against certain cancers.

Strengthening Europe in the fight against cancer in BECA committee: extracts and presentation of the the draft report

During the plenary session (5-8 July 2021) of the European Parliament in Strasbourg, MEPs debate on European Medicines Agency.

European Medicines Agency: MEPs debate

During the plenary session (7-10 June 2021) in the European Parliament in Strasbourg, MEPs debate on EU Digital COVID Certificate: MEPs debate 2/3

Joint debate on EU Digital COVID Certificate: MEPs debate 2/3

Members of the Special Committee on Beating Cancer (BECA) discuss the impact of the COVID-19 pandemic on cancer prevention, health services and cancer patients and research, in the European Parliament in Brussels. Extracts from the meeting. Statements by Mark LAWLER , Co-Chair of the European Cancer Organisation Special Network on Impact of COVID-19 on Cancer, Solange PETERS, President, European Society for Medical Oncology (ESMO), Dineke ZEEGERS PAGET, Executive Director, European Public Health Association (EUPHA), Véronique TRILLET-LENOIR (Renew, FR), Co-rapporteur, and Bartosz ARŁUKOWICZ (EPP, PL), BECA Chair and Co-rapporteur.

The impact of the COVID-19 pandemic on cancer prevention, health services and cancer patients and research: extracts from BECA Committee meeting

Members of the Committee on the Environment, Public Health and Food Safety (ENVI) exchange views on the update of evaluation and authorization of COVID-19 vaccines, with Emer COOKE, Executive Director of the European Medicines Agency's (EMA), in the European Parliament in Brussels. Questions & answers

Update of evaluation and authorization of COVID-19 vaccines - Exchange of views with Emer COOKE, EMA Executive Director: questions & answers

During the plenary session of the European Parliament in Brussels (08-11 March 2021), MEPs debate on the programme for the Union's action in the field of health for the period 2021-2027 (“EU4Health Programme”): MEPs debate 1/3

Programme for the Union's action in the field of health for the period 2021-2027 (“EU4Health Programme”): MEPs debate 1/3

Members of the Committee on the Environment, Public Health and Food Safety (ENVI) and the Committee on Industry, Research and Energy (ITRE) have a joint hearing on "How to increase the capacity of COVID 19 vaccine production and improve delivery". Q&A with CEOs of the pharmaceutical industry Paul STOFFELS, Vice Chair of the Executive Committee and Chief Scientific Officer, Johnson & Johnson, Angela HWANG, President Global Biopharma, Pfizer Group, accompanied by Germain MORIN, VP Vaccines Supply Chain, Thomas TRIOMPHE, Executive Vice-President, Head of Sanofi Pasteur ,Suerie MOON, Co-Director, Global Health Centre, Graduate Institute of International and Development Studies, Geneva.

Joint hearing of the ENVI and ITRE Committee - "How to increase the capacity of COVID 19 vaccine production and improve delivery": Q&A with ENVI and ITRE Members and CEOs of the pharmaceutical industry

Véronique TRILLET-LENOIR (Renew, FR), rapporteur of the Special EP Committee for Beating Cancer (BECA), gives a statement on the Europe's first Beating Cancer Plan. The plan is structured around four key areas: prevention, early detection, diagnosis and treatment, and improving quality of life. There are multiple supporting actions, along ten flagship initiatives.

Europe Beating Cancer Plan: statement by Véronique TRILLET-LENOIR (Renew, FR), rapporteur of the Special EP Committee for Beating Cancer

Emer COOKE, Executive Director of the European Medicines Agency, answers questions posed by the members of the Committee on the Environment, Public Health and Food Safety on vaccine authorisation, availability and deployment.

Exchange of views with Emer COOKE, Executive Director of the European Medicines Agency EP Committee on the Environment, Public Health and Food Safety: questions/answers with the MEPs

During the plenary session in Brussels (11-13 November 2020) MEPs debate the programme for the Union's action in the field of health for the period 2021-2027 (“EU4Health Programme”). MEPs debate (part 1)

Programme for the Union's action in the field of health for the period 2021-2027 (“EU4Health Programme”): MEPs debate (part 1)

MEPS from the Committee on the Environment, Public Health and Food Safety (ENVI) and from the Committee on Industry, Research and Energy (ITRE) hold a public hearing with researchers and representatives from pharmaceutical companies and civil society organisations on how to secure access to COVID-19 vaccines for all, including challenges linked to clinical trials, production and distribution in the European Parliament in Brussels.

How to secure access to COVID-19 vaccines for EU citizens; clinical trials, production and distribution challenges: extracts from the joint public hearing

Public Hearing of Members of the Committee on the Environment, Public Health and Food Safety and the EP Committee on Industry, Research and Energy with Thomas TRIOMPHE, Executive Vice President, Sanofi Pasteur, Jean STEPHENNE, Chairman of the Supervisory Board, accompanied by Pierre Kemula, Chief Financial Officer, CureVac, Fergus SWEENEY, Head of Clinical Studies and Manufacturing Task Force, European Medicines Agency, Professor Robin SHATTOCK, Faculty of Medicine, Department of Infectious Disease, Imperial College London, Dr Sidney WONG, Director, Médecins Sans Frontières Access Campaign, Magdalena RODRIGUEZ de AZERO, Executive Director, Vaccines Europe, European Federation of Pharmaceutical Industries and Associations. Part 1 of 2 Q&A with ENVI and ITRE Members.

Public Hearing on How to secure access to COVID-19 vaccines for EU citizens: clinical trials, production and distribution challenges. Joint EP Committee ENVI and ITRE. 1/2 Q&A with ENVI and ITRE Members.

45 tulemust